Scott Thomas Jackson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Thomas Jackson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Thomas Jackson. Scott Thomas Jackson is Director in GLYCOMIMETICS INC ($GLYC) and Director in MACROGENICS INC ($MGNX) and Chief Executive Officer in Celator Pharmaceuticals Inc ($CPXX) and Director in Spero Therapeutics, Inc. ($SPRO).
Latest Insider Trading Transactions of Scott Thomas Jackson
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CPXX, GLYC, MGNX, SPRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17 2021 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 28.88 | 15,000 | 433,200 | 15,000 | |
| Oct 27 2020 | SPRO | Spero Therapeutics ... | Jackson Scott Thomas | Director | Option Exercise | A | 13.52 | 7,500 | 101,400 | 7,500 | |
| Jun 23 2020 | SPRO | Spero Therapeutics ... | Jackson Scott Thomas | Director | Option Exercise | A | 13.94 | 15,000 | 209,100 | 15,000 | |
| May 15 2020 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 24.97 | 15,000 | 374,550 | 15,000 | |
| May 21 2019 | GLYC | GLYCOMIMETICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 12.39 | 21,000 | 260,190 | 21,000 | |
| May 20 2019 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 18.00 | 10,000 | 180,000 | 10,000 | |
| Nov 28 2018 | GLYC | GLYCOMIMETICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 11.52 | 22,000 | 253,440 | 22,000 | |
| May 21 2018 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
| May 22 2017 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
| Jan 25 2017 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 18.52 | 20,000 | 370,400 | 20,000 | |
| Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 1.32 | 118,835 | 156,862 | 0 | |
| Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 1.32 | 295,000 | 389,400 | 0 | |
| Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 2.79 | 175,000 | 488,250 | 0 | |
| Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 3.22 | 157,000 | 505,540 | 0 | |
| Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 3.12 | 333,724 | 1,039,884 | 0 | |
| Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 2.44 | 98,409 | 240,118 | 0 | |
| Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Sell | D | 30.25 | 301,518 | 9,120,920 | 0 | 301.5 K to 0 (-100.00 %) |
| Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | M | 3.12 | 96,276 | 299,996 | 333,724 | |
| Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | M | 2.44 | 117,064 | 285,636 | 98,409 | |
| Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | M | 3.37 | 38,135 | 128,515 | 0 | |
| Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | M | 3.12 | 96,276 | 299,996 | 301,518 | 205.2 K to 301.5 K (+46.91 %) |
| Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | M | 2.44 | 117,064 | 285,636 | 205,242 | 88.2 K to 205.2 K (+132.76 %) |
| Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | M | 3.37 | 38,135 | 128,515 | 88,178 | 50 K to 88.2 K (+76.20 %) |
| Jan 29 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | A | 1.32 | 118,835 | 156,862 | 118,835 | |
| Jan 29 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | A | 1.32 | 295,000 | 389,400 | 295,000 | |
| Oct 07 2015 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | P | 1.74 | 14,450 | 25,143 | 50,043 | 35.6 K to 50 K (+40.60 %) |
| Feb 27 2015 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | A | 2.79 | 175,000 | 488,250 | 175,000 | |
| Feb 27 2015 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Grant | A | 0.00 | 22,593 | 0 | 35,593 | 13 K to 35.6 K (+173.79 %) |
Page: 1